Statistics

Total Visits

Views
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial46

Select a period of time:

Number of views in the range

Views
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial6

Views

Views
October 20250
November 20250
December 20250
January 20260
February 20260
March 20261
April 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Angola1
Canada1
 

Top cities views

Views
Los Angeles1
Miami1
Montreal1